Biogenesis and Functions of Circular RNAs (Part II)
There are also a few more biological functions of circular RNAs that have been uncovered so far. Transcription regulation is especially common amongst ciRNAs and EIciRNAs with introns retained (basically circular RNAs with introns can regulate transcription). They regulate transcription by interacting with the U1 snRNP and RNA Polymerase II.
Alternative splicing can result from the biogenesis (creation) of circular RNAs, so another role of circular RNAs is to help facilitate alternative splicing through their own creation. This implies that the biogenesis of circular RNAs from a pre-mRNA strand is actually competing against and dysregulating the normal canonical pre-mRNA splicing in order to facilitate alternative splicing.
Another role of circular RNAs is to regulate parental gene translation. They do this if the circular RNA contains the AUG start codon for translation, so the remaining exons from the RNA that the circular RNA was made out of won’t have a start codon, and thus won’t get translated. This indirectly reduces the translation of parental genes.
Some circular RNAs also help to regulate progression through the cell cycle. One circular RNA known to do this is circ-Foxo3 (forkhead box O3). The circular RNA Foxo3 binds to p21 and CDK2 to regulate progression through the cell cycle. P21 is a protein that inhibits CDK2, and CDK2 is a cyclin dependent kinase (enzyme), which is supposed to be active in only the G1 and S phase and needs to be shut off for mitosis to proceed.
Circular RNAs can also be a protein sponge. CircMBL binds to the muscleblind protein (MBNL) and sponges out any extra MBNL proteins. The MBNL protein was shown to be ‘implicated’ in myotonic dystrophy which causes muscle loss and weakness (I’m still not too sure if too much MBNL is good or bad). Some other examples of RNA-Binding Proteins that can bind to circular RNAs are argonaute (AGO1, AGO2) which is needed for gene silencing and micro RNA processing, EIF4A3 (eukaryotic initiation factor) which is a translation initiation factor #4A3 (i.e. starts translation), FMR1 (fragile X mental retardation) which is a polysome-associated protein (a polysome is a cluster of ribosomes held together by the mRNA that they’re translating) that helps neuronal development and synaptic plasticity by regulating mRNA splicing and mRNA stability. There is also RNA demethylase ALKBH5, and other proteins which can be sponged by circular RNAs. You can imagine that there are many proteins capable of being sponged by compatible circular RNAs, so these protein sponges can end up affecting all the functions that these proteins were supposed to carry out such as gene silencing, miRNA processing, translation initiation, neuronal development, etc.
Another role of circular RNAs is to help facilitate m6A-driven translation. m6A is N6-methyladenosine. If a circular RNA contains an RRACH sequence with m6A, then that circular RNA can drive the initiation of translation. R is a purine (adenine or guanine), A is m6A (N6-methyladenosine), C is cytosine, and H is a non-guanine base (adenine, cytosine, or uracil). Basically, this just means that we can translate the circular RNA into protein products if it has an m6A inside a RRACH sequence. How this works is, MTTL3 and MTTL14 form a heterodimer (the two join together. MTTL is MeThylTransferase-Like protein), and they methylate an adenosine. FTO stands for alpha-ketoglutarate-dependent dioxygenase, and FTO can come and de-methylate a methylated circular RNA. So, after the MTTL complex methylates the circular RNA at an adenosine, the YTHDF3 protein can come and bind to the m6A, and then this recruits the EIF4G2 (eukaryotic translation initiation factor), which also recruits the 43S preinitiation complex (made of a bunch of eIF proteins) and then translation can occur. Another way to translate circular RNAs is actually through an Internal Ribosomal Entry Site (IRES). A circular RNA could have an IRES motif sticking out of it, which allows RNA Binding Proteins to latch onto the IRES motif and go along the circular RNA. Some microRNAs and silencing RNAs (siRNAs) are also involved in this mechanism.
Another function of circular RNAs is to act as a microRNA sponge. In order to be a miRNA sponge, the circular RNA must have a microRNA Response Element (MRE) which lets the circular RNA bind micro RNAs and thus reduce binding of microRNAs to their intended targets. Normally, miRNAs tend to bind to argonaute proteins. Even though it was demonstrated that some specific circular RNAs have the MRE which allows them to bind miRNAs, in actuality the majority of circular RNAs DO NOT have the ability to act as miRNA sponges.
In total, the field of endogenous circular RNAs is a new and very fast-moving field of research. If there are any problems with the RNA splicing mechanism in the body, then it will be reflected by the generation of circular RNAs. Thus, a last possible function of circular RNAs is to act as a disease biomarker. Circular RNAs are pretty stable inside a cell due to being able to resist exonucleases. Plus, circular RNAs are normally expressed in certain cell and tissue types. So not only can circular RNAs be used as a diagnostic tool for specific cancers or diseases, they might also be able to become a therapeutic tool. It’s possible to use silencing RNAs (siRNA) to target specific circular RNAs for downregulation.
For example, the circular CCDC66 and CiRS-7 RNAs are found in colorectal cancers (CRC). It’s also possible to find circular RNAs in bodily fluids such as saliva and in plasma, which makes them easy to collect from patients. Circular RNAs are also stable in exosomes (basically a bunch of vesicles that are inside one larger vesicle that gets fused into the membrane so all the smaller vesicles inside are released outside). These exosomes contain tumor-specific circular RNA and are released by tumor cells in order to protect the circular RNAs from RNases (enzymes that degrade RNA) found in extracellular fluid (fluid outside the cells, like your blood or whatever). When these circular RNAs inside exosomes enter the blood, we can draw them out and measure their presence in blood for cancer detection. This can allow us to identify patients with early stage colon cancer through only a blood test.
In many cancers, most circular RNAs are expressed at levels different to their normal expression (either over or under expressed). Circular RNAs have a huge role in gene regulation through their ability to bind miRNAs and proteins, so it’s expected that they would one of the things to go haywire in a cancerous cell. Now we just need to explore if abnormal circular RNA levels are the cause or consequence of cancers. Another example of circular RNA in cancer is circ-Foxo3 in breast cancer. Circ-Foxo3 increases FOXO3 protein levels which also raises the amount of the downstream target of FOXO3, which is PUMA. Circ-Foxo3 also repressed p53 levels by making MDM-2 ubiquitinate p53 more than usual, and the ubiquitination caused the degradation of p53. The main thing to remember is that circ-Foxo3 ends up affecting breast cancer in many ways, and circular RNAs can be both suppressive and oncogenic (causing cancer) depending on which circular RNA we are talking about and how much there is in the cell. Thus, there is no real ‘circular RNA is universally good or bad’, but having a proper balance of them in the cell is important for cell function.